CLIFFSIDE LABS L.L.C.
NPI 1518366426
Clinical Medical Laboratory in Monmouth, NJ

NPI Status: Active since August 15, 2014

Contact Information

7 DEER PARK DRIVE, STE K
MONMOUTH, NJ
ZIP 08852
Phone: (609) 964-7620
Fax: (732) 647-1225

Get Directions Write a Review

NPPES record last updated: September 25, 2023. Verified against the NPPES registry weekly; last sync: July 12, 2026.

  • Organization
  • Clinical Medical Laboratory
  • CLIA Number: 31D2096452
  • CLIA Cert. Type: Independent
  • CLIA Exp. Date: 02-10-2026

About CLIFFSIDE LABS L.L.C.

This page provides the complete NPI Profile along with additional information for Cliffside Labs L.l.c., a provider established in Monmouth, New Jersey operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1518366426 assigned on August 2014. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 3 years ago. The authorized official of this NPI record is Liam J Dunne (Authorized Official)

NPI
1518366426
Provider Name
CLIFFSIDE LABS L.L.C.
Entity Type
Organization
Location Address
7 DEER PARK DRIVE, STE K MONMOUTH, NJ 08852
Location Phone
(609) 964-7620
Location Fax
(732) 647-1225
Mailing Address
7 DEER PARK DRIVE, STE K MONMOUTH, NJ 08852
Mailing Phone
(609) 964-7620
Mailing Fax
(732) 647-1225
Is Sole Proprietor?
No
Is Organization Subpart?
No
Enumeration Date
08-15-2014
Last Update Date
09-25-2023
Code Navigator

Establishments like Cliffside Labs L.l.c. are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.

Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification

Clinical Medical Laboratory

Taxonomy Code
291U00000X
Type
Laboratories
Taxonomy Description
(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name

LIAM J DUNNE

Authorized Official Title
AUTHORIZED OFFICIAL
Authorized Official Phone
(609) 964-7620

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

A definitive drug test identifies specific drugs in your system. Advanced methods like GC/MS (Gas Chromatography/Mass Spectrometry) and LC/MS (Liquid Chromatography/Mass Spectrometry) are used. These can distinguish between similar drugs, providing precise results.

This service was performed 57 times for 22 patients

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

A definitive drug test identifies specific drugs in your system. It uses advanced methods like gc/ms and lc/ms, which can distinguish between different types of drugs but not necessarily their 3D forms. This test offers detailed results to support your healthcare decisions.

This service was performed 29 times for 25 patients

Gene analysis (adenomatous polyposis coli), duplication or deletion variants

Gene analysis of the adenomatous polyposis coli is a test that detects changes in the APC gene. These changes may cause certain health conditions. Duplication or deletion variants refer to parts of the gene being repeated or missing. This information helps tailor treatment plans.

This service was performed 832 times for 832 patients

Gene analysis (adenomatous polyposis coli), full gene sequence

Gene analysis of the adenomatous polyposis coli (APC) involves studying the entire sequence of the APC gene. This test helps identify mutations that could lead to conditions like familial adenomatous polyposis. The procedure is non-invasive and uses a blood sample.

This service was performed 818 times for 818 patients

Gene analysis (bloom syndrome, recq helicase-like)

Gene analysis for Bloom Syndrome involves studying the RECQ helicase-like gene. This gene is responsible for DNA repair. When it's not working properly, it can lead to Bloom Syndrome, a condition that increases the risk of developing various types of cancer.

This service was performed 5,007 times for 5,003 patients

Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants

Gene analysis for breast cancer 1 and 2 involves studying your DNA to detect alterations that may increase your risk of developing certain health issues. This test analyzes the full sequence and checks for duplication or deletion variants.

This service was performed 742 times for 742 patients

Gene analysis (breast cancer 2) of full sequence

Gene analysis (breast cancer 2) of full sequence is a test that studies your DNA to identify any changes or mutations in the genes associated with an increased risk of certain types of cancer.

This service was performed 38 times for 38 patients

Gene analysis (coagulation factor ix) full sequence analysis

Gene analysis for coagulation factor IX is a process that examines your genes, specifically the one responsible for factor IX - a protein that helps blood clot. It can detect any changes or mutations in this gene, which could affect your body's ability to control bleeding.

This service was performed 3,111 times for 3,111 patients

Gene analysis (coagulation factor v) leiden variant

Gene analysis for the coagulation factor V Leiden variant is a test to identify a specific genetic mutation. This mutation can increase the risk of developing abnormal blood clots in veins. The test involves analyzing a sample of your DNA, usually taken from a blood sample.

This service was performed 27 times for 27 patients

Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence

Gene analysis for cystic fibrosis involves examining the entire CFTR gene to identify any changes or mutations that could cause the disease. This can help in diagnosing and managing the condition effectively.

This service was performed 3,570 times for 3,566 patients

Gene analysis (fanconi anemia, complementation group c) common variant

Gene analysis for Fanconi Anemia, Complementation Group C, is a test that looks at your DNA to see if you have changes in a specific gene linked to this type of anemia. This can help determine if you have the condition or if you might pass it on to your children.

This service was performed 4,960 times for 4,960 patients

Gene analysis (glucose-6-phosphatase, catalytic subunit) common variants

Gene analysis of glucose-6-phosphatase, catalytic subunit, common variants involves studying specific genes related to glucose metabolism. This helps understand if you're at risk of certain metabolic disorders. It's a non-invasive procedure, involving a simple blood or saliva sample.

This service was performed 3,489 times for 3,489 patients

Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis

Gene analysis for glucose-6-phosphate dehydrogenase (G6PD) involves studying your DNA to check for changes in the G6PD gene. This gene controls an enzyme that helps red blood cells function properly. Anomalies can cause health issues like anemia.

This service was performed 3,457 times for 3,457 patients

Gene analysis (janus kinase 2) targeted sequence analysis

Gene analysis, specifically Janus Kinase 2 (JAK2) targeted sequence analysis, is a lab test that studies a specific gene in your body. It helps identify changes or mutations in the JAK2 gene, which can be linked to certain health conditions. This analysis is performed on a blood or bone marrow sample.

This service was performed 3,606 times for 3,597 patients

Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10

Gene analysis of the MPL proto-oncogene, thrombopoietin receptor, specifically sequence analysis of exon 10, is a procedure that studies a specific part of your DNA. It helps to identify any changes or mutations that may contribute to certain blood disorders.

This service was performed 3,606 times for 3,597 patients

Gene analysis (mutl homolog 1, colon cancer, nonpolyposis type 2) duplication or deletion variants

Gene analysis for MLH1 is a test that checks for changes in the MLH1 gene, which if altered, can increase the risk of colon cancer. Duplication or deletion variants refer to extra or missing copies of the gene. This can help in early detection and prevention.

This service was performed 209 times for 209 patients

Gene analysis (mutl homolog 1, colon cancer, nonpolyposis type 2) full sequence analysis

Gene analysis, specifically for MUTL Homolog 1, linked to colon cancer, involves studying your DNA sequence. This helps identify any changes or mutations that might increase your risk of developing colon cancer. It's a preventive measure to manage potential health risks.

This service was performed 105 times for 105 patients

Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) duplication or deletion variants

Gene analysis for MUTS homolog 2 (colon cancer, nonpolyposis type 1) duplication or deletion variants is a test that looks for changes in a specific gene linked to a higher risk of colon cancer. It helps identify if you carry these gene changes, aiding in early detection and prevention.

This service was performed 604 times for 604 patients

Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis

Gene analysis (MUTYH) full sequence analysis is a test that examines your DNA to identify any changes linked to nonpolyposis colon cancer type 1. This can help determine your risk of developing this type of cancer.

This service was performed 822 times for 822 patients

Gene analysis (muts homolog 6 [e coli]) duplication or deletion variants

Gene analysis (muts homolog 6 [e coli]) duplication or deletion variants is a genetic test. It identifies changes in your DNA that could indicate certain health conditions. This test looks specifically at the mutS homolog 6 gene for any duplications or deletions.

This service was performed 1,694 times for 1,694 patients

Gene analysis (muts homolog 6 [e coli]) full sequence analysis

Gene analysis, specifically MUTS Homolog 6 (E. coli) full sequence analysis, is a test that examines your DNA to identify changes in the MUTS Homolog 6 gene. This information helps doctors understand and manage potential health concerns.

This service was performed 4,033 times for 4,033 patients

Gene analysis (myeloid differentiation primary response 88) for p.leu265pro variant

Gene analysis for the p.Leu265Pro variant involves studying the MYD88 gene, which plays a crucial role in immune response. This test helps identify changes in this gene that could potentially cause health issues. It's a non-invasive procedure, done through a blood sample.

This service was performed 28 times for 28 patients

Gene analysis (partner and localizer of brca2) full sequence analysis

Gene analysis, specifically for the partner and localizer of BRCA2, involves examining your genetic code to identify any changes in this particular gene. This gene is significant in maintaining the health of your cells. The full sequence analysis means we look at every part of this gene to ensure it's working properly.

This service was performed 5,199 times for 5,159 patients

Gene analysis (phosphatase and tensin homolog), duplication or deletion variant

Gene analysis for phosphatase and tensin homolog (PTEN) involves studying this specific gene for any duplications or deletions. These changes can impact health and may be associated with certain conditions. This test helps in understanding your genetic makeup better.

This service was performed 100 times for 100 patients

Gene analysis (phosphatase and tensin homolog), full sequence analysis

Gene analysis, specifically phosphatase and tensin homolog (PTEN) full sequence analysis, is a test that looks at your DNA to identify any changes in the PTEN gene. This gene helps control cell growth and division. Changes may lead to certain health conditions.

This service was performed 113 times for 113 patients

Gene analysis (phospholipase c gamma 2) for common variants

Gene analysis for phospholipase C gamma 2 common variants is a test that checks for changes in the PLCG2 gene. These changes can sometimes lead to certain health conditions. The test uses a sample of your body's cells to analyze your DNA.

This service was performed 28 times for 28 patients

Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) duplication or deletion variants

Gene analysis for PMS2 duplication or deletion variants involves studying your DNA to detect changes in the PMS2 gene. This gene is important for DNA repair. Variations in this gene could potentially lead to certain health conditions. This test helps to identify these changes early.

This service was performed 1,679 times for 1,679 patients

Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis

Gene analysis, specifically postmeiotic segregation increased 2 (s cerevisiae) full sequence analysis, is a scientific procedure. It involves studying your entire genetic code to identify any changes or differences that could be related to certain health conditions. This is done in a lab, using a sample provided by you.

This service was performed 4,701 times for 4,701 patients

Gene analysis (runt related transcription factor 1) targeted sequence analysis

Gene analysis for RUNX1 involves studying a specific part of your DNA. This test helps identify changes or mutations in the RUNX1 gene, which can provide insights into certain health conditions. It's like reading a book to find any spelling mistakes that could change the story.

This service was performed 35 times for 35 patients

Gene analysis (telomerase reverse transcriptase) targeted sequence analysis

Gene analysis of telomerase reverse transcriptase (TERT) involves studying a specific segment of your DNA. It helps understand how your body's cells age and multiply, which can be crucial in diagnosing and managing certain health conditions.

This service was performed 26 times for 26 patients

Gene analysis (tumor protein 53) full sequence analysis

Gene analysis, specifically tumor protein 53 (TP53) full sequence analysis, is a test that examines the entire TP53 gene. This gene plays a key role in preventing cancer. If there are changes or mutations in this gene, it could lead to an increased risk of developing various types of cancer.

This service was performed 21 times for 21 patients

Gene analysis for cancer (neuroblastoma)

Gene analysis for neuroblastoma is a test that studies your genes to identify abnormalities linked to this type of cancer. It helps doctors tailor treatment plans, potentially improving outcomes and reducing side effects.

This service was performed 48 times for 48 patients

Molecular pathology procedure level 4

A Molecular Pathology Procedure Level 4 is a sophisticated lab test that analyzes your DNA. It helps identify specific genetic changes that may be causing or increasing the risk of certain diseases. This understanding can aid in diagnosis, treatment, and prevention strategies.

This service was performed 13 times for 13 patients

Molecular pathology procedure level 5

A Molecular Pathology Procedure Level 5 is a complex lab test that studies genes and proteins at a molecular level. It helps identify genetic changes or infections that may cause or influence disease. This information is crucial for diagnosis and treatment planning.

This service was performed 13 times for 13 patients

Molecular pathology procedure level 6 genetic analysis

A molecular pathology procedure level 6 genetic analysis is a complex lab test. It examines your DNA to identify specific genetic changes that can cause or increase the risk of disease. Understanding these changes can help in tailoring treatments.

This service was performed 13 times for 13 patients

Test for detecting genes associated with colon cancer, genomic sequence analysis panel, at least 10 genes

This is a genetic test that checks for specific genes linked to colon cancer. The test analyzes a minimum of 10 genes to identify any changes or mutations that may increase the risk of developing this type of cancer.

This service was performed 846 times for 846 patients

Testing for presence of drug, by chemistry analyzers

Chemistry analyzers are used to detect the presence of drugs in your system. This test involves taking a small sample of your blood or urine. The sample is then analyzed for specific substances. The results help in understanding your health condition better.

This service was performed 87 times for 30 patients

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number
31D2096452
Facility Type
Independent
Certificate Effective Date
February 11, 2024
Certificate Expiration Date
February 10, 2026
Laboratory Director
DONALD L. WARKENTIN
Certificate Type
Certificate of Compliance
Certificate Type Description
This CLIA certificate is issued to Cliffside Labs L.l.c. after an inspection that finds the laboratory to be in compliance with all applicable CLIA requirements. This type of certificate is issued to laboratories that perform nonwaived (moderate and/or high complexity) testing.

Reviews for CLIFFSIDE LABS L.L.C.

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

NPI Number Validation

How NPI Validation Works

The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.

To verify the NPI 1518366426, we treat the final digit (6) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 64. The final step is to find the difference between that total and the next multiple of ten (70 - 64 = 6).

Digit-by-digit view

Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.

Pos 1
1
Doubled → 2
Pos 2
5
Unchanged
Pos 3
1
Doubled → 2
Pos 4
8
Unchanged
Pos 5
3
Doubled → 6
Pos 6
6
Unchanged
Pos 7
6
Doubled → 12 → 1 + 2
Pos 8
4
Unchanged
Pos 9
2
Doubled → 4
Check
6
Target digit
Regular digit Doubled digit Check digit

Step 1: Double every other digit from the right

Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.

1 → 2 1 → 2 3 → 6 6 → 12 → 3 2 → 4

Step 2: Add all digits plus the NPI constant

Add the transformed values, the unchanged digits, and the constant 24.

2 + 5 + 2 + 8 + 6 + 6 + 1 + 2 + 4 + 4 + 24 = 64

Step 3: Find the amount needed to reach the next multiple of 10

The next multiple of ten after 64 is 70. The difference is the calculated check digit.

70 - 64 = 6
This NPI is valid
The calculated check digit is 6, which matches the last digit of 1518366426.

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1518366426, enumerated as an "organization" on August 15, 2014.

The provider is located at 7 DEER PARK DRIVE, STE K MONMOUTH, NJ 08852 and the phone number is (609) 964-7620.

Clinical Medical Laboratory with taxonomy code 291U00000X.